Literature DB >> 31064841

The role of lipids in α-synuclein misfolding and neurotoxicity.

Cathryn L Ugalde1,2,3,4, Victoria A Lawson2, David I Finkelstein3, Andrew F Hill5,4.   

Abstract

The misfolding and aggregation of α-synuclein (αsyn) in the central nervous system is associated with a group of neurodegenerative disorders referred to as the synucleinopathies. In addition to being a pathological hallmark of disease, it is now well-established that upon misfolding, αsyn acquires pathogenic properties, such as neurotoxicity, that can contribute to disease development. The mechanisms that produce αsyn misfolding and the molecular events underlying the neuronal damage caused by these misfolded species are not well-defined. A consistent observation that may be relevant to αsyn's pathogenicity is its ability to associate with lipids. This appears important not only to how αsyn aggregates, but also to the mechanism by which the misfolded protein causes intracellular damage. This review discusses the current literature reporting a role of lipids in αsyn misfolding and neurotoxicity in various synucleinopathy disorders and provides an overview of current methods to assess protein misfolding and pathogenicity both in vitro and in vivo.
© 2019 Ugalde et al.

Entities:  

Keywords:  Lewy body; Parkinson disease; alpha-synuclein; amyloid; lipid; mitochondrial function; neurodegeneration; neurodegenerative disease; neurotoxicity; protein misfolding; synucleinopathy

Mesh:

Substances:

Year:  2019        PMID: 31064841      PMCID: PMC6556586          DOI: 10.1074/jbc.REV119.007500

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  181 in total

1.  α-synuclein promotes neuroprotection through NF-κB-mediated transcriptional regulation of protein kinase Cδ.

Authors:  Reina Aoki; Yun Rose Li
Journal:  Sci Signal       Date:  2011-10-18       Impact factor: 8.192

2.  α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.

Authors:  Bruno Fauvet; Martial K Mbefo; Mohamed-Bilal Fares; Carole Desobry; Sarah Michael; Mustafa T Ardah; Elpida Tsika; Philippe Coune; Michel Prudent; Niels Lion; David Eliezer; Darren J Moore; Bernard Schneider; Patrick Aebischer; Omar M El-Agnaf; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Characterization of conformational and dynamic properties of natively unfolded human and mouse alpha-synuclein ensembles by NMR: implication for aggregation.

Authors:  Kuen-Phon Wu; Seho Kim; David A Fela; Jean Baum
Journal:  J Mol Biol       Date:  2008-03-18       Impact factor: 5.469

4.  Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes.

Authors:  Andreas van Maarschalkerweerd; Valeria Vetri; Bente Vestergaard
Journal:  FEBS Lett       Date:  2015-08-20       Impact factor: 4.124

5.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

7.  Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Authors:  Eunsung Junn; Ruben D Ronchetti; Martha M Quezado; Soo-Youl Kim; M Maral Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

8.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

9.  Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement.

Authors:  Christine C Jao; Balachandra G Hegde; Jeannie Chen; Ian S Haworth; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-09       Impact factor: 11.205

10.  Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Authors:  Latha Devi; Vijayendran Raghavendran; Badanavalu M Prabhu; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

View more
  13 in total

Review 1.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

Review 2.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

3.  Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding.

Authors:  Robert W Newberry; Taylor Arhar; Jean Costello; George C Hartoularos; Alison M Maxwell; Zun Zar Chi Naing; Maureen Pittman; Nishith R Reddy; Daniel M C Schwarz; Douglas R Wassarman; Taia S Wu; Daniel Barrero; Christa Caggiano; Adam Catching; Taylor B Cavazos; Laurel S Estes; Bryan Faust; Elissa A Fink; Miriam A Goldman; Yessica K Gomez; M Grace Gordon; Laura M Gunsalus; Nick Hoppe; Maru Jaime-Garza; Matthew C Johnson; Matthew G Jones; Andrew F Kung; Kyle E Lopez; Jared Lumpe; Calla Martyn; Elizabeth E McCarthy; Lakshmi E Miller-Vedam; Erik J Navarro; Aji Palar; Jenna Pellegrino; Wren Saylor; Christina A Stephens; Jack Strickland; Hayarpi Torosyan; Stephanie A Wankowicz; Daniel R Wong; Garrett Wong; Sy Redding; Eric D Chow; William F DeGrado; Martin Kampmann
Journal:  ACS Chem Biol       Date:  2020-08-12       Impact factor: 5.100

4.  Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells.

Authors:  Cathryn L Ugalde; Sarah J Annesley; Shane E Gordon; Katelyn Mroczek; Matthew A Perugini; Victoria A Lawson; Paul R Fisher; David I Finkelstein; Andrew F Hill
Journal:  Dis Model Mech       Date:  2020-01-17       Impact factor: 5.758

Review 5.  Gut brain axis: an insight into microbiota role in Parkinson's disease.

Authors:  Sara Ayman Moustafa; Shrouk Mohamed; Abdelhameed Dawood; Jihan Azar; Ekramy Elmorsy; Noura A M Rizk; Mohamed Salama
Journal:  Metab Brain Dis       Date:  2021-08-09       Impact factor: 3.584

6.  Structural and mechanistic insights into amyloid-β and α-synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers.

Authors:  Henry M Sanders; Blagojce Jovcevski; Michael T Marty; Tara L Pukala
Journal:  FEBS J       Date:  2021-07-26       Impact factor: 5.542

7.  A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.

Authors:  Diana M Hendrickx; Pierre Garcia; Amer Ashrafi; Alessia Sciortino; Kristopher J Schmit; Heike Kollmus; Nathalie Nicot; Tony Kaoma; Laurent Vallar; Manuel Buttini; Enrico Glaab
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

8.  Seeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification.

Authors:  Simon Nicot; Jérémy Verchère; Maxime Bélondrade; Charly Mayran; Dominique Bétemps; Daisy Bougard; Thierry Baron
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.834

9.  A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol.

Authors:  Fitnat Buket Basmanav; Felipe Opazo; Christoph Gerdes; Natalia Waal; Thomas Offner; Eugenio F Fornasiero; Nora Wender; Hannes Verbarg; Ivan Manzini; Claudia Trenkwalder; Brit Mollenhauer; Timo Strohäker; Markus Zweckstetter; Stefan Becker; Silvio O Rizzoli
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

10.  Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson's Disease.

Authors:  Shanshan Hu; Meigui Hu; Jian Liu; Bei Zhang; Zhen Zhang; Fiona H Zhou; Liping Wang; Jianghui Dong
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-04       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.